Exact Sciences Corporation provided earnings guidance for the first quarter and year 2024. For the quarter, the company expected total revenue between $615 million and $630 million, screening revenue between $460 million and $470 million and Precision Oncology revenue between $155 million and $160 million.

For the year, the company expects total revenue of $2.810 billion - $2.850 billion, assuming Screening revenue of $2.155 billion - $2.175 billion, and Precision Oncology revenue of $655 million - $675 million.